Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Posaconazole. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 19/20 | 0.71 |
| ▸ | CYP19A1 | P11511 | 5/20 | 0.71 |
| ▸ | ABCG2 | Q9UNQ0 | 4/20 | 0.71 |
| ▸ | CYP17A1 | P05093 | 4/20 | 0.71 |
| ▸ | ABCB11 | O95342 | 3/20 | 0.71 |
| ▸ | CYP8B1 | Q9UNU6 | 3/20 | 0.71 |
| ▸ | CYP11B1 | P15538 | 3/20 | 0.71 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.71 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.71 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.71 |
| ▸ | MAPT | P10636 | 3/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.61 |
| ▸ | MEN1 | O00255 | 2/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.61 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.61 |
| ▸ | CYP51A1 | Q16850 | 2/20 | 0.61 |
| ▸ | FYN | P06241 | 1/20 | 0.61 |
| ▸ | CXCR1 | P25024 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Posaconazole SCHEMBL4024855 | 0.91 | CYP3A4 (0.78) | CYP3A4CYP19A1ABCG2CYP17A1ABCB11 | |
| Posaconazole SCHEMBL20703831 | 0.86 | CYP3A4 (0.70) | CYP3A4CYP19A1ABCG2CYP17A1ABCB11 | |
| Itraconazole SCHEMBL28208896 | 0.86 | CYP3A4 (0.83) | CYP3A4CYP19A1ABCG2CYP17A1ABCB11 | |
| Itraconazole SCHEMBL6129429 | 0.86 | CYP3A4 (0.83) | CYP3A4CYP19A1ABCG2CYP17A1ABCB11 | |
| Itraconazole SCHEMBL3675418 | 0.85 | CYP3A4 (0.70) | CYP3A4CYP19A1ABCG2CYP17A1ABCB11 | |
| Posaconazole SCHEMBL23871970 | 0.84 | CYP3A4 (1.00) | CYP3A4CYP19A1ABCG2CYP17A1ABCB11 | |
| Posaconazole SCHEMBL1455343 | 0.84 | CYP3A4 (1.00) | CYP3A4CYP19A1ABCG2CYP17A1ABCB11 | |
| Posaconazole SCHEMBL18857056 | 0.84 | CYP3A4 (1.00) | CYP3A4CYP19A1ABCG2CYP17A1ABCB11 | |
| Posaconazole SCHEMBL20930912 | 0.84 | CYP3A4 (1.00) | CYP3A4CYP19A1ABCG2CYP17A1ABCB11 | |
| Posaconazole SCHEMBL13575780 | 0.84 | CYP3A4 (1.00) | CYP3A4CYP19A1ABCG2CYP17A1ABCB11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008021970-A2 | TREATMENT OF MOTOR NEURON DISEASE, INCLUDING CERTAIN NEUROLOGICAL DISORDERS, MOTOR NEUROPATHIES AND CHRONIC INFLAMMATORY DISEASES | REID WILLIAM K (US) | 2008-02-21 | — | — | WO | claimed |
| WO-2008021970-A2 | TREATMENT OF MOTOR NEURON DISEASE, INCLUDING CERTAIN NEUROLOGICAL DISORDERS, MOTOR NEUROPATHIES AND CHRONIC INFLAMMATORY DISEASES | REID WILLIAM K (US) | 2008-02-21 | — | — | WO | disclosed |